OTXL’s COO, Beth White, notes that the CGT marketplace could revitalise programmes that would otherwise have been indefinitely put on ice.

On Thursday, the American Society of Gene & Cell Therapy (ASGCT) and the Orphan Therapeutics Accelerator (OTXL) debuted a joint clearinghouse for shelved drug programs

OTXL’s COO, Beth White, notes that the CGT marketplace could revitalise programmes that would otherwise have been indefinitely put on ice.